跳至主要内容
临床试验/EUCTR2006-005715-10-GB
EUCTR2006-005715-10-GB进行中(未招募)不适用

The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). - The CHIP Trial

Royal Brompton & Harefield NHS Trust0 个研究点目标入组 1,500 人开始时间: 2007年3月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children from birth to <16 years who are undergoing intensive care treatment with an arterial line in-situ and receiving both mechanical ventilation and vasoactive support drugs following injury, major surgery or in association with critical illness in whom it is anticipated such treatment will be required to continue for at least 12 hours.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Children born pre-term and who are < 36 weeks corrected gestation
  • Children with diabetes mellitus
  • Children with an established or suspected diagnosis of an inborn error of metabolism
  • Children for whom treatment withdrawal or limitation of intensive care treatment is being considered
  • Children who have been in a PICU for more than 5 days in succession
  • Children admitted to a PICU who have already participated in the CHIP study during a previous PICU admission.

研究者

发起方
Royal Brompton & Harefield NHS Trust

相似试验